The p.P479L variant in CPT1A is associated with infectious disease in a BC First Nation
- PMID: 30996616
- PMCID: PMC6462176
- DOI: 10.1093/pch/pxy106
The p.P479L variant in CPT1A is associated with infectious disease in a BC First Nation
Abstract
Background: The hepatic carnitine palmitoyltransferase I (CPT1A) p.P479L variant is common in Aboriginal populations across coastal British Columbia, Alaska, the Canadian North, and Greenland. While the high frequency of this variant suggests positive selection, other studies have shown an association with sudden unexpected death in infancy and infection. We utilized administrative health data to evaluate hospitalizations for a single year cohort of children of First Nations descent genotyped for the variant and, matched for location of birth. Seven years of data were reviewed for 150 children split evenly between CPT1A genotypes (homozyous, heterozygous, and noncarrier of the p.P479L variant).
Results: Children homozygous for the p.P479L allele had a higher rate of hospital admissions at 2.6 per individual as compared to noncarriers at 0.86. Heterozygous children also showed a significant increase at 1.9 per person. Length of stay per admission was increased for both p.P479L homozygotes and heterozygotes. The odds ratio (OR) for at least one hospitalization for any reason was increased for p.P479L homozygotes relative to noncarriers (OR=10.2, confidence interval [CI] 3.5 to 30.0) as were admissions for dental caries (OR=3.4, CI 1.5 to 7.8), acute lower respiratory tract infections (OR=6.0, CI 1.6 to 22.4), and otitis media (OR=13.5, CI 1.7 to 109.4).
Conclusions: The CPT1A p.P479L variant is associated with an increased rate of hospitalization for those homozygous, primarily for infectious disease causes. Heterozygotes also showed a small but significant increase in hospitalization rates suggesting some dosage effect. Functional studies will be required to identify the underlying pathological mechanism.
Keywords: Carnitine palmitoyltransferase; Fatty acid oxidation; First Nation; Indigenous; Infection.
Similar articles
-
Association of the CPT1A p.P479L Metabolic Gene Variant With Childhood Respiratory and Other Infectious Illness in Nunavut.Front Pediatr. 2021 Jul 6;9:678553. doi: 10.3389/fped.2021.678553. eCollection 2021. Front Pediatr. 2021. PMID: 34295859 Free PMC article.
-
Carnitine palmitoyltransferase I and sudden unexpected infant death in British Columbia First Nations.Pediatrics. 2012 Nov;130(5):e1162-9. doi: 10.1542/peds.2011-2924. Epub 2012 Oct 22. Pediatrics. 2012. PMID: 23090344
-
Carnitine palmitoyltransferase 1A (CPT1A) P479L prevalence in live newborns in Yukon, Northwest Territories, and Nunavut.Mol Genet Metab. 2010 Oct-Nov;101(2-3):200-4. doi: 10.1016/j.ymgme.2010.07.013. Epub 2010 Jul 24. Mol Genet Metab. 2010. PMID: 20696606
-
Carnitine palmitoyltransferase 1A P479L and infant death: policy implications of emerging data.Genet Med. 2017 Aug;19(8):851-857. doi: 10.1038/gim.2016.202. Epub 2017 Jan 26. Genet Med. 2017. PMID: 28125087 Free PMC article. Review.
-
Otitis media in Greenland. Studies on historical, epidemiological, microbiological, and immunological aspects.Int J Circumpolar Health. 2001;60 Suppl 2:1-54. Int J Circumpolar Health. 2001. PMID: 11725622 Review.
Cited by
-
Alcohol promotes CPT1A-induced lipid metabolism disorder to sentinel-regulate acute pancreatitis.Eur J Med Res. 2025 Jan 17;30(1):35. doi: 10.1186/s40001-024-02213-8. Eur J Med Res. 2025. PMID: 39819476 Free PMC article.
-
Neutrophil trafficking to the site of infection requires Cpt1a-dependent fatty acid β-oxidation.Commun Biol. 2022 Dec 13;5(1):1366. doi: 10.1038/s42003-022-04339-z. Commun Biol. 2022. PMID: 36513703 Free PMC article.
-
Neonatal hypoglycemia and the CPT1A P479L variant in term newborns: A retrospective cohort study of Inuit newborns from Kivalliq Nunavut.Paediatr Child Health. 2020 Apr 3;26(4):218-227. doi: 10.1093/pch/pxaa039. eCollection 2021 Jul. Paediatr Child Health. 2020. PMID: 34131458 Free PMC article.
-
Ketohexokinase-C regulates global protein acetylation to decrease carnitine palmitoyltransferase 1a-mediated fatty acid oxidation.J Hepatol. 2023 Jul;79(1):25-42. doi: 10.1016/j.jhep.2023.02.010. Epub 2023 Feb 21. J Hepatol. 2023. PMID: 36822479 Free PMC article.
-
Association of the CPT1A p.P479L Metabolic Gene Variant With Childhood Respiratory and Other Infectious Illness in Nunavut.Front Pediatr. 2021 Jul 6;9:678553. doi: 10.3389/fped.2021.678553. eCollection 2021. Front Pediatr. 2021. PMID: 34295859 Free PMC article.
References
-
- Bartlett K, Eaton S. Mitochondrial beta-oxidation. Eur J Biochem 2004;271(3):462–9. - PubMed
-
- Gessner BD, Gillingham MB, Johnson MA, et al. . Prevalence and distribution of the c.1436c→t sequence variant of carnitine palmitoyltransferase 1A among Alaska native infants. J Pediatr 2011;158(1):124–9. - PubMed
-
- Collins SA, Sinclair G, McIntosh S, et al. . Carnitine palmitoyltransferase 1A (CPT1A) P479L prevalence in live newborns in Yukon, northwest territories, and Nunavut. Mol Genet Metab 2010;101(2–3):200–4. - PubMed
-
- Sinclair GB, Collins S, Popescu O, McFadden D, Arbour L, Vallance HD. Carnitine palmitoyltransferase I and sudden unexpected infant death in British Columbia First Nations. Pediatrics 2012;130(5):e1162–9. - PubMed
LinkOut - more resources
Full Text Sources